Sema3D, an agonist for both np1 and np2 [26], inhibited tumor formation completely in one experiment (data not shown) and in another experiment inhibited strongly though not completely tumor development even though it was not as highly expressed as the other semaphorins (Fig. 3, E–F). Here, NRP2 is linked to neoplasm.